Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05762796 · ClinicalTrials.gov registry record · NA

Neuromodulation and Neuroimaging in Older Children With Mild Traumatic Brain Injury

A NA study of Cognitive Impairment and Mild Traumatic Brain Injury, sponsored by State University of New York at Buffalo.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT05762796: Recruiting NA study of Cognitive Impairment and Mild Traumatic Brain Injury, sponsored by State University of New York at Buffalo.

NCT05762796 is a NA study of Cognitive Impairment and Mild Traumatic Brain Injury that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 10 participants, below the 666-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05762796, a NA study of Cognitive Impairment and Mild Traumatic Brain Injury, is actively recruiting participants, sponsored by State University of New York at Buffalo.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Mild traumatic brain injury (mTBI) often causes persistent motor and cognitive deficits in children resulting in functional limitations. We are testing a brain stimulation method along with evaluating objective tools to help record and restore communication among affected brain areas, which will facilitate recovery in youth after mTBI.

Primary Outcome

The PANESS is used to assess static and dynamic postural stability of adolescents. The PANESS contains nine static and dynamic balance tasks: 1) walking on heels, 2) walking on toes, 3) walking on sides of feet, 4) double-legged stance, 5) single-legged stance for 30 seconds, 6) tandems stance for 20 seconds, 7) forward tandem walking, 8) backward tandem walking, and 9) hopping in place on one foot. The scores from all tasks are combined to form an aggregated score.

Interventions

  • DEVICE tDCS in Youth with mild traumatic brain injury

Study Locations (1)

New York

  • Ghazala Saleem - Buffalo

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2024-02-20
Est. Completion 2027-06
Phase NA

What NCT05762796 shows while recruiting

NCT05762796 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 666-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (98% lower).

The record links to 4 conditions, with Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which tDCS in Youth with mild traumatic brain injury is the first listed.

NCT05762796 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05762796 about?

NCT05762796 is a clinical study titled "Neuromodulation and Neuroimaging in Older Children With Mild Traumatic Brain Injury". Mild traumatic brain injury (mTBI) often causes persistent motor and cognitive deficits in children resulting in functional limitations. We are testing a brain stimulation method along with evaluating objective tools to help record and restore communication among affected brain areas, which will fac...

What is the current status of trial NCT05762796?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-02-20. Estimated completion is 2027-06.

What conditions does trial NCT05762796 study?

This clinical trial studies the following conditions: Cognitive Impairment, Mild Traumatic Brain Injury, Brain Concussion, Motor Disorders.

What interventions are being tested in trial NCT05762796?

The interventions under investigation include: tDCS in Youth with mild traumatic brain injury (DEVICE).

Who is sponsoring clinical trial NCT05762796?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05762796 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05762796's enrollment target sits among peer trials

10 102nd of 105 higher than 2 of 105 other Cognitive Impairment trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05762796, the US trial registry maintained by the National Library of Medicine. NCT05762796 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.